VP, Clinical Operations
PellePharm, Inc.
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name VP, Clinical Operations as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-11 19:35 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05466890 · Phase 2a to Evaluate PL-8177 in Subjects with Active Ulcerative Colitis (UC)Palatin Technologies, Inc · active not recruiting · Ulcerative Colitis, Ulcerative Colitis Acute, Ulcerative
- Ph3NCT04308395 · Extension Study of Patidegib Topical Gel, 2% in Subjects With Gorlin Syndrome (Basal Cell Nevus Syndrome)Sol-Gel Technologies, Ltd. · terminated · Basal Cell Nevus Syndrome · study director
- Ph2NCT04155190 · A Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas in Patients With Non-Gorlin High Frequency BCCSol-Gel Technologies, Ltd. · terminated · Recurrent Basal Cell Carcinoma · study director
- Ph3NCT03703310 · Study of Patidegib Topical Gel, 2%, for the Reduction of Disease Burden of Persistently Developing Basal Cell Carcinomas (BCCs) in Subjects With Basal Cell Nevus Syndrome (Gorlin Syndrome)Sol-Gel Technologies, Ltd. · completed · Basal Cell Nevus Syndrome · study director
Grants
NIH projects from RePORTER, fetched 2026-11-11 19:35 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
PubMed returned no clinical-trial papers for this author name.